Treatment of Atrial Fibrillation in Patients With Chronic Kidney Disease Is Stroke Prevention Worth the Risk?

被引:3
|
作者
Shahid, Farhan [1 ]
Shantsila, Eduard [1 ]
Lip, Gregory Y. H. [1 ,2 ]
机构
[1] Univ Birmingham, Inst Cardiovasc Sci, City Hosp, Birmingham B18 7QH, W Midlands, England
[2] Aalborg Univ, Aalborg Thrombosis Res Unit, Dept Clin Med, Aalborg, Denmark
关键词
ORAL ANTICOAGULANTS; WARFARIN; MORTALITY; EFFICACY; OUTCOMES; SAFETY;
D O I
10.1016/j.chest.2015.09.026
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:891 / 892
页数:2
相关论文
共 50 条
  • [1] Stroke Prevention in Atrial Fibrillation Patients With Chronic Kidney Disease
    Hart, Robert G.
    Eikelboom, John W.
    Brimble, K. Scott
    McMurtry, M. Sean
    Ingram, Alistair J.
    [J]. CANADIAN JOURNAL OF CARDIOLOGY, 2013, 29 (07) : S71 - S78
  • [2] Stroke Prevention in Atrial Fibrillation in Patients With Chronic Kidney Disease
    Qamar, Arman
    Bhatt, Deepak L.
    [J]. CIRCULATION, 2016, 133 (15) : 1512 - 1515
  • [3] The Risk of Stroke and Stroke Type in Patients With Atrial Fibrillation and Chronic Kidney Disease
    Mace-Brickman, Trevor
    Eddeen, Anan Bader
    Carrero, Juan-Jesus
    Mark, Patrick B.
    Molnar, Amber O.
    Lam, Ngan N.
    Zimmerman, Deborah
    Harel, Ziv
    Sood, Manish M.
    [J]. CANADIAN JOURNAL OF KIDNEY HEALTH AND DISEASE, 2019, 6
  • [4] Incident atrial fibrillation and the risk of stroke in patients with chronic kidney disease
    Szummer, K.
    Trevisan, M.
    Barany, P.
    Xu, H.
    Evans, M.
    Carrero, J. J.
    [J]. EUROPEAN HEART JOURNAL, 2017, 38 : 974 - 974
  • [6] Novel anticoagulants for stroke prevention in atrial fibrillation and chronic kidney disease
    Turagam, Mohit K.
    Addepally, Naga S.
    Velagapudi, Poonam
    [J]. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2013, 11 (10) : 1297 - 1299
  • [7] Impact of chronic kidney disease on left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation
    Kefer, Joelle
    Tzikas, Apostolos
    Freixa, Xavier
    Shakir, Samera
    Gafoor, Sameer
    Nielsen-Kudsk, Jens Erik
    Berti, Sergio
    Santoro, Gennaro
    Aminian, Adel
    Landmesser, Ulf
    Nietlispach, Fabian
    Ibrahim, Reda
    Danna, Paolo Luciano
    Benit, Edouard
    Budts, Werner
    Stammen, Francis
    De Potter, Tom
    Tichelbaecker, Tobias
    Gloekler, Steffen
    Kanagaratnam, Prapa
    Costa, Marco
    Cruz-Gonzalez, Ignacio
    Sievert, Horst
    Schillinger, Wolfgang
    Park, Jai-Wun
    Meier, Bernhard
    Omran, Heyder
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 207 : 335 - 340
  • [8] Risk of Stroke, Bleeding, and Death in Patients with Nonvalvular Atrial Fibrillation and Chronic Kidney Disease
    Arnson, Yoav
    Hoshen, Moshe
    Berliner-Sendrey, Adi
    Reges, Orna
    Balicer, Ran
    Leibowitz, Morton
    Tsadok, Meytal Avgil
    Haim, Moti
    [J]. CARDIOLOGY, 2020, 145 (03) : 178 - 186
  • [9] Stroke Risk and Efficacy of Apixaban in Atrial Fibrillation Patients with Moderate Chronic Kidney Disease
    Eikelboom, John W.
    Connolly, Stuart J.
    Gao, Peggy
    Paolasso, Ernesto
    De Caterina, Raffaele
    Husted, Steen
    O'Donnell, Martin
    Yusuf, Salim
    Hart, Robert G.
    [J]. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2012, 21 (06): : 429 - 435
  • [10] Comparison of Stroke and Bleeding Risk Profile in Patients With Atrial Fibrillation and Chronic Kidney Disease
    Barcia, Jose Antonio Parada
    Roubin, Sergio Raposeiras
    Abu-Assi, Emad
    Erquicia, Pablo Dominguez
    Castro, Andrea Lizancos
    Leston, Lucia Rioboo
    Miguez, Juan Ocampo
    Bermudez, Inmaculada Gonzalez
    Iniguez-Romo, Andres
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2023, 196 : 31 - 37